- Quality - 50% of total score: Select 6 measures including one Outcome measure (or high priority measure if an outcome measure is not applicable) and report each on 60% of eligible Medicare and non-Medicare patient/visits for the full year. Suggestions for your specialty include but are not limited to the following:
- #46 Medication reconciliation: Reconciliation after discharge from an inpatient facility - High Priority
- #47 Care Plan - High Priority
- #110 Preventive Care and Screening: Influenza Immunization
- #111 Pneumonia Vaccination Status for Older Adults
- #128 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up Plan
- #130 Documentation and Verification of Current Medications in the Medical Record* High Priority Note: This measures is reported/counted for every eligible Medicare patient visit vs. once per reporting period).
- #131 Pain Assessment and Follow-up High Priority Note: This measures is reported/counted for every eligible Medicare patient visit vs. once per reporting period).
- #137 Melanoma: Continuity of Care-Recall System* High Priority
- #138 Melanoma: Coordination of Care* High Priority
- #205 HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphillis
- #224 Melanoma: Overutilization of Imaging Studies in Melanoma* High Priority
- #226 Tobacco Use: Screening and Cessation Intervention*
- #265 Biopsy Follow-Up* High Priority
- #317 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented*
- #337 Tuberculosis Prevention for Psoriasis and Psoriatic Arthritis Patients on a Biological Immune Response Modifier*
- #358 Patient-Centered Surgical Risk Assessment and Communication Note: This measure requires the use of a specific risk calculator.
- #374 Closing the Referral Loop: Receipt of Specialist Report* - High Priority
- #402 Tobacco Use and Help with Quitting Among Adolescents*
- #410 Psoriasis: Clinical Response to Oral Systemic or Biologic Medications*
- #431 Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
- #440 Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time - Pathologist to Clinician* - High Priority
- *These 12 registry measures are part of the Dermatology Specialty Measures set.
- PI: Promoting Interoperability (formerly ACI) - 25% of total score: Replaces the Medicare EHR Incentive Program also known as Meaningful Use. A minimum of the following base measures are required if reporting this category. Note that EHR's certified to a 2014 edition report a different set of measures.
- IA: Improvement Activities - 15% of total score: Attest that you completed up to 2 high-weighted activities or 4 medium-weighted activities for a minimum of 90 days. Groups with 15 or fewer participants or if you are in a rural or health professional shortage area, attest that you completed 1 high-weighted or 2 medium-weighted activities for a minimum of 90 days. There are over 90 possible measures to choose from. The following are suggestions only:
- Collection and use of patient experience and satisfaction data on access (medium weighted).
- Annual registration in the Prescription Drug Monitoring Program (medium weighted).
- Engagement of new Medicaid patients and follow-up (high weighted).
- Engage patients and families to guide improvement in the system of care (medium weighted).
- Implementation of documentation improvements for practice/process improvements (medium weighted).
- Implementation of improvements that contribute to more timely communication of test results (medium weighted).
